Vivos Inc. (OTCMKTS:RDGL) Sees Large Decline in Short Interest

Vivos Inc. (OTCMKTS:RDGL) was the target of a significant decrease in short interest in January. As of January 15th, there was short interest totalling 25,300 shares, a decrease of 61.0% from the December 31st total of 64,900 shares. Based on an average trading volume of 3,461,200 shares, the short-interest ratio is presently 0.0 days.

Vivos Price Performance

OTCMKTS RDGL traded down $0.00 during trading hours on Tuesday, reaching $0.13. The company’s stock had a trading volume of 1,304,411 shares, compared to its average volume of 1,318,772. The firm has a fifty day simple moving average of $0.11 and a 200-day simple moving average of $0.13. The stock has a market cap of $56.18 million, a P/E ratio of -12.70 and a beta of 0.91. Vivos has a 52 week low of $0.05 and a 52 week high of $0.26.

About Vivos

Vivos Inc, a radiation oncology medical device company, develops brachytherapy devices for the treatment of non-resectable tumors in the United States. It develops yttrium-90 based RadioGel device, an injectable particle-gel for brachytherapy radiation treatment of cancerous tumors in people and animals; and IsoPet for the treatment of solid tumors in animals.